Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Explore B7-33 Peptide at Pharma Lab Global UK, a research peptide investigated for its anti-fibrotic properties and potential to reduce excessive scarring
Factor TB-500 weekly exposure (typical) Pre-blended 1:1 vial 1.257.0 mg/week (steady, daily) Separate vials 4.010.0 mg/week (pulsed, 2x/week loading) Factor Reconstitution complexity Pre-blended 1:1 vial One vial Separate vials Two vials, two reconstitution steps Factor Best for Pre-blended 1:1 vial Simplicity, steady exposure Separate vials Injury-focused planning, dose tuning Both formats cover the same total compounds
Not for human consumption or clinical application
It is primarily investigated for its regenerative and cytoprotective properties across multiple tissue types, including muscle, tendon, ligament, and gastrointestinal mucosa
A research-grade BPC-157 COA should show an HPLC chromatogram with a purity percentage of 99% or higher, mass spectrometry confirming identity matching the GEPPPGKPADDAGLV sequence (molecular weight 1419 Da), a batch or lot number, testing date, and analytical laboratory name
Pinch a fold of subcutaneous tissue, insert at the studied subcutaneous angle, and keep at least an inch of separation from a recent site
